148 related articles for article (PubMed ID: 20029452)
1. Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Catafau AM; Searle GE; Bullich S; Gunn RN; Rabiner EA; Herance R; Radua J; Farre M; Laruelle M
J Cereb Blood Flow Metab; 2010 May; 30(5):985-93. PubMed ID: 20029452
[TBL] [Abstract][Full Text] [Related]
2. In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia.
Poels EM; Girgis RR; Thompson JL; Slifstein M; Abi-Dargham A
Psychopharmacology (Berl); 2013 Jul; 228(1):167-74. PubMed ID: 23460265
[TBL] [Abstract][Full Text] [Related]
3. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.
Tsukada H; Miyasato K; Nishiyama S; Fukumoto D; Kakiuchi T; Domino EF
Neuropsychopharmacology; 2005 Dec; 30(12):2144-53. PubMed ID: 15856080
[TBL] [Abstract][Full Text] [Related]
4. Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride.
Slifstein M; Suckow RF; Javitch JA; Cooper T; Lieberman J; Abi-Dargham A
J Cereb Blood Flow Metab; 2011 Jan; 31(1):293-304. PubMed ID: 20571519
[TBL] [Abstract][Full Text] [Related]
5. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
Kosaka J; Takahashi H; Ito H; Takano A; Fujimura Y; Matsumoto R; Nozaki S; Yasuno F; Okubo Y; Kishimoto T; Suhara T
Life Sci; 2010 May; 86(21-22):814-8. PubMed ID: 20361984
[TBL] [Abstract][Full Text] [Related]
6. [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects.
Slifstein M; Kegeles LS; Gonzales R; Frankle WG; Xu X; Laruelle M; Abi-Dargham A
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1733-41. PubMed ID: 17311076
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
[TBL] [Abstract][Full Text] [Related]
10. In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390.
Ekelund J; Slifstein M; Narendran R; Guillin O; Belani H; Guo NN; Hwang Y; Hwang DR; Abi-Dargham A; Laruelle M
Mol Imaging Biol; 2007; 9(3):117-25. PubMed ID: 17473957
[TBL] [Abstract][Full Text] [Related]
11. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Halldin C; Foged C; Farde L; Karlsson P; Hansen K; Grønvald F; Swahn CG; Hall H; Sedvall G
Nucl Med Biol; 1993 Nov; 20(8):945-53. PubMed ID: 8298574
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
[TBL] [Abstract][Full Text] [Related]
13. Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
Abi-Dargham A; Xu X; Thompson JL; Gil R; Kegeles LS; Urban N; Narendran R; Hwang DR; Laruelle M; Slifstein M
J Psychopharmacol; 2012 Jun; 26(6):794-805. PubMed ID: 21768159
[TBL] [Abstract][Full Text] [Related]
14. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
15. COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET.
Slifstein M; Kolachana B; Simpson EH; Tabares P; Cheng B; Duvall M; Frankle WG; Weinberger DR; Laruelle M; Abi-Dargham A
Mol Psychiatry; 2008 Aug; 13(8):821-7. PubMed ID: 18317466
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.
Ettrup A; da Cunha-Bang S; McMahon B; Lehel S; Dyssegaard A; Skibsted AW; Jørgensen LM; Hansen M; Baandrup AO; Bache S; Svarer C; Kristensen JL; Gillings N; Madsen J; Knudsen GM
J Cereb Blood Flow Metab; 2014 Jul; 34(7):1188-96. PubMed ID: 24780897
[TBL] [Abstract][Full Text] [Related]
17. In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: two dopamine D-1 receptor agonist ligands.
DaSilva JN; Wilson AA; Valente CM; Hussey D; Wilson D; Houle S
Life Sci; 1996; 58(19):1661-70. PubMed ID: 8632703
[TBL] [Abstract][Full Text] [Related]
18. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
20. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
